Sansure Biotech Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
47.97 | 98.17 | -51.14% | 23.16 | +107.08% |
| P/S |
|
9.07 | 15.43 | -41.24% |
|
|
| P/BV |
|
1.8 | 5.38 | -66.52% |
|
|
| P/FCF |
|
-87.13 | -14.74 | 491.04% |
|
|
| Ev/Ebitda |
|
3.86 | 18.15 | -78.74% |
|
|
| Ev/S |
|
5.89 | 17.01 | -65.34% |
|
|
| Ev/FCF |
|
-58.59 | 13.46 | -535.21% |
|
|
| E/P |
|
0.0216 | 0.0234 | -7.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
180.38 | -42.13 | -528.16% | 76.7 | +135.17% |
| ROE |
|
3.82 | 2.36 | 61.7% |
|
|
| ROA |
|
3.23 | 2.84 | 13.84% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.9 | -55.5 | -134.05% |
|
|
| ROCE |
|
31.86 | 1.47 | 2070.47% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1542 | 0.934 | -83.49% | 0.0384 | +302.14% |
| Nеt Debt/Ebitda |
|
-1.59 | -0.0069 | 22795.89% |
|
|
| Debt/Ratio |
|
0.0471 | 0.1161 | -59.37% |
|
|
| Debt/Equity |
|
0.1713 | 0.9055 | -81.09% |
|
|
| Debt/Net Income |
|
1.47 | 6.08 | -75.8% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6/10
|
2.4 | 0.331 | 625.1% | 4.1 | -41.42% |
| Number of years of dividend growth |
|
1 | 1.05 | -4.59% | ||
| DSI |
|
0.8571 | 0.6686 | 28.2% |
|
|
| Average dividend growth |
|
4.39 | -3.73 | -217.62% |
|
|
| Average percentage for 5 years |
|
4.1 | 1.5 | 173.14% |
|
|
| Average percentage for payments |
|
172.61 | 85.51 | 101.85% |
|
|
| Difference from average difference in sector |
|
2.07 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-69.39 | 25.7 | -370% | ||
| Growth impulse Ebitda in 5 years |
|
3583.12 | 13.87 | 25733.6% | ||
| Growth impulse Net Income in 5 years |
|
-89.47 | 253.87 | -135.24% | ||
| Growth impulse FCF in 5 years |
|
-105.79 | 62.85 | -268.32% | ||
| Growth impulse EPS in 5 years |
|
-79.77 | 24.33 | -427.87% |
IP Score
5.77/10
